Testing different schedules for an infant malaria vaccine
Treatments studied
Part of Infections clinical trials.
This trial is testing whether giving the R21 malaria vaccine to infants at different ages (starting at 2 months or 3 months) works as well as starting at 6 weeks. It will help find the best schedule to protect babies against malaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is full-term (born at 37 weeks or later) and weighed more than 5.5 pounds at birth.
- Your baby is between 42 and 49 days old at enrollment.
- You are willing to bring your baby to all study visits and not travel for 28 days after each vaccination.
- Your baby does not have a serious health condition, such as a heart, lung, or kidney problem, or a weak immune system.
- Your baby has not already received certain other vaccines or a malaria vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two ways of giving the R21 malaria vaccine to children in Chad during the rainy season. One way follows the routine vaccination schedule, and the other gives the vaccine at the same time as seasonal malaria prevention medication.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This Phase 1/2 study tests a new vaccine meant to protect young children against malaria. If you qualify, your baby would get the study vaccine and be followed for about 12 months to check safety and early signs of protection.
This study looks at how well the R21/Matrix-M malaria vaccine works and how safe it is in children who received it. It compares children who got malaria (or died) to healthy children who also got the vaccine.
This trial tests a seasonal vaccination schedule with the R21 malaria vaccine to help eliminate malaria in your community. It may be a good fit if you are looking for a way to protect yourself or your child from malaria during peak transmission seasons.
Hear when a new Malaria Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.